phosphatidylcholines has been researched along with Osteosarcoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Fujimoto, T; Murase, O; Ogasawara, Y; Ohsaki, Y; Tatematsu, T; Uchida, M; Yoshikawa, S | 1 |
| Ma, ZA; Zhang, XH; Zhao, C | 1 |
| Kaye, SB; Ryman, BE | 1 |
| Auberger, T; Lemmen, P; Probst, T; Weissfloch, L | 1 |
| Auberger, T; Bremer, M; Lemmen, P; Molls, M; Peller, M; Probst, T; Senekowitsch-Schmidtke, R; Tempel, K; Wagner, M; Weissfloch, L | 1 |
| An, T; Jia, SF; Kleinerman, ES; Worth, LL | 1 |
| Kunnel, JG; Radeff, JM; Singh, AT; Stern, PH | 1 |
| Gilbert, BE; Giovanella, BC; Kleinerman, ES; Knight, V; Koshkina, NV; Waldrep, JC | 1 |
| Jeha, SS; Kleinerman, ES; Worth, LL | 1 |
1 review(s) available for phosphatidylcholines and Osteosarcoma
| Article | Year |
|---|---|
Biologic response modifiers in pediatric cancer.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytokines; Drug Design; Hematopoietic Cell Growth Factors; Humans; Immunologic Factors; Immunotherapy; Infant; Interleukins; Isotretinoin; Liposomes; Neoplasms; Neuroblastoma; Osteosarcoma; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Salvage Therapy; Sarcoma, Ewing | 2001 |
8 other study(ies) available for phosphatidylcholines and Osteosarcoma
| Article | Year |
|---|---|
Long-term autophagy is sustained by activation of CCTβ3 on lipid droplets.
Topics: Animals; Autophagosomes; Autophagy; Cell Line, Tumor; Cell Survival; Choline-Phosphate Cytidylyltransferase; Culture Media; Enzyme Activation; Fibroblasts; Gene Knockdown Techniques; Humans; Lipid Droplets; Mice; Models, Biological; Mouse Embryonic Stem Cells; Osteosarcoma; Phosphatidylcholines | 2020 |
The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Group VI Phospholipases A2; HCT116 Cells; Humans; In Situ Nick-End Labeling; Insulin-Secreting Cells; Models, Biological; Naphthalenes; Osteosarcoma; Phosphatidylcholines; Phosphorylation; Protein Serine-Threonine Kinases; Pyrones; Rats; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2007 |
The fate of liposome-entrapped actinomycin D in vivo and its therapeutic effect in a solid murine tumour [proceedings].
Topics: Animals; Dactinomycin; Drug Stability; Kinetics; Liposomes; Mice; Osteosarcoma; Phosphatidylcholines; Sarcoma, Experimental | 1980 |
Uptake and distribution of the boron-containing ether lipid B-Et-11-OMe in tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Boranes; Boron Neutron Capture Therapy; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microwaves; Neoplasm Transplantation; Osteosarcoma; Phosphatidylcholines; Rats; Tissue Distribution | 1995 |
New drugs for BNCT: an experimental approach.
Topics: Animals; Boranes; Boron Neutron Capture Therapy; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Osteosarcoma; Phosphatidylcholines; Tissue Distribution | 1999 |
ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Breast Neoplasms; Carcinoma; Cells, Cultured; Cytokines; Cytotoxicity, Immunologic; Gene Expression Regulation; Humans; Interleukins; Liposomes; Macrophage-Activating Factors; Melanoma; Monocytes; Osteosarcoma; Phosphatidylcholines; Phosphatidylglycerols; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Bridged-Ring Compounds; Choline; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Humans; Hydrolysis; Isoenzymes; Norbornanes; Osteosarcoma; Parathyroid Hormone; Phosphatidylcholines; Signal Transduction; Temperature; Thiocarbamates; Thiones; Tritium; Tumor Cells, Cultured; Type C Phospholipases | 2000 |
9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
Topics: Aerosols; Animals; Antineoplastic Agents; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron; Osteosarcoma; Particle Size; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2000 |